CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Mahkam Zanganeh

Co-Chief Executive Officer, President and Director, Summit Therapeutics Inc.

Search every verified Mahkam Zanganeh interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Mahkam Zanganeh, co-chief executive officer of Summit Therapeutics, discussed the company's experimental lung cancer treatment in a September 2024 interview. She said the drug, which beat Keytruda in a head-to-head trial conducted in China, is being studied in additional indications including head and neck and breast cancer. Zanganeh noted that the company is enrolling patients in the United States and Europe for phase three trials, adding that the patient population is not limited to Chinese patients. In a November 2025 appearance at the WE Convention, Zanganeh recounted her childhood during the Iranian Revolution and her career transition from pediatric dentistry to biotech. She described her leadership philosophy, stating that she does not follow money but instead focuses on building something, and advised women to take ownership of their choices and prioritize their time. She also mentioned that Summit Therapeutics' market capitalization grew from $250 million to over $15 billion over three years, and that she, her partner, and her son hold 80% of the company.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →